HIV Flashcards

1
Q

what type of organism is HIV

A

retrovirus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

which strain of HIV is more virulent, type 1 or 2

A

HIV 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

which immune cells are targeted by HIV

A

CD4 cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what effects on CD4 does HIV have

A

reduced circulating CD4 cells
reduced proliferation of CD4 cells
reduced CD8 cells
chronic immune activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the normal range of CD4 cells

A

500-1600 cells/mm3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

a CD4 cell count of what puts individuals at risk of opportunistic infection

A

<200

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how is HIV transmitted

A

through sexual contact - anal, vaginal, oral
transplacentally
via breast milk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

outline some of the clinical features of primary HIV infection

A
fever
maculopapular rash 
pharyngitis 
mucosal ulceration 
myalgia 
lymphadenopathy 
headache/aseptic meningitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what opportunistic infections are HIV patients at risk of

A
pneumocystis jirovecii 
TB
toxoplasma gondii 
CMV
EBV 
Kaposii's sarcoma 
Lymphoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how does pneumocystis jirovecii present

A

shortness of breath
malaise
dry cough
CXR shows perihilar infiltrates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how does toxoplama gondii present

A

toxoplasma abscess - commonly in brain
focal neuro signs, seizures, features of raised ICP
ring enhancing lesions on MRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

EBV increases risk of what conditions

A

non-hodgkins lymphoma

oral hairy leukoplakia, white patch on side of tongue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

describe Kaposii’s sarcoma

A

AIDS defining condition, due to human herpes virus 8

either cutaneous or mucosal lesion, patch, plaque or nodular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

which specific lymphomas are HIV patients at increased risk of

A

non-hodgkin lymphoma - Burkitt lymphoma

primary CNS lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

outline some groups at increased risk of developing HIV

A

men who have sex with men
women who have sex with MSM
people who inject drugs
children and adults from endemic countries such as South Africa, Thailand and Caribbean

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the 3 preventative measures to prevent HIV spread

A

barrier methods
pre-exposure prophylaxis
post-exposure prophylaxis

17
Q

how does PEP work

A

short term use of ART after potential exposure

can be given up to 72 hours after exposure

18
Q

how does PrEP work

A

similar to COCP, at risk groups can take regularly before exposure to prevent infection

19
Q

what is the main treatment for HIV and what is the aim of it

A

anti retroviral therapy

aim is to achieve an undetectable viral load and preserve immune function

20
Q

when is ART commenced in HIV patients

A

anyone with diagnosis of HIV irrespective of CD4+ count

21
Q

outline some of the drug classifications that are used as ART drugs

A

nucleoside reverse transcriptase inhibitors (NRTIs)
non-nucleoside reverse transcriptase inhibitors (NNRTIs)
protease inhibitors

22
Q

what is the first line treatment for HIV

A

HAART - highly active antiretroviral therapy

23
Q

what drugs are involves in HAART

A

2 nucleoside reverse transcriptase inhibitors as backbone combined with either 1 NNRTI or 1 PI
(3 drugs in total)

24
Q

give examples of NRTIs

A

tenofovir
zidovudine
abacavir

25
Q

give examples of NNRTIs

A

nevirapine
etravirine
rilpivirine

26
Q

give examples of protease inhibitors

A

darunavir

atazanavir

27
Q

what are some of the toxicity problems associated with HAART

A
GI effects
skin rash and steven johnston syndrome 
proximal renal tubulopathies 
osteomalacia - tenofovir 
increased risk of MI 
anaemia - zidovudine